Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody that specifically targets activin receptor-like kinase 1 (ALK-1). Demonstrating a high binding affinity, Ascrinvacumab interacts with human ALK1 with a dissociation constant (Kd) of 7 nM. This antibody is primarily utilized in scientific studies focused on the pathogenesis and therapeutic interventions of hepatocellular carcinoma (HCC).
Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody that specifically targets activin receptor-like kinase 1 (ALK-1). Demonstrating a high binding affinity, Ascrinvacumab interacts with human ALK1 with a dissociation constant (Kd) of 7 nM. This antibody is primarily utilized in scientific studies focused on the pathogenesis and therapeutic interventions of hepatocellular carcinoma (HCC).
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: